CliffBio

UCB

Patent cliffs & loss of exclusivity

A biopharmaceutical company focusing on discovery and development of treatments for neurology and immunology conditions

Company

Also Known AsUCB-celltech
AngelList URLhttps://angel.co/ucb-2
Legal NameUCB S.A.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/ucb-pharma
Facebook URLhttps://www.facebook.com/UCBBiopharma
Fax Number+32 2 559 99 00
Full AddressAllée de la Recherche, 60 1070 Brussels Belgium

32 upcoming patent cliffs

DrugIngredientTypeCliff
  1. Cimziacertolizumab pegolBiologicApr 2020
  2. BRIVIACTBRIVARACETAMSmall mol.Feb 2026
  3. BRIVIACTBRIVARACETAMSmall mol.Feb 2026
  4. VIMPATLACOSAMIDESmall mol.Apr 2026
  5. VIMPATLACOSAMIDESmall mol.Apr 2026
  6. VIMPATLACOSAMIDESmall mol.Apr 2026
  7. VIMPATLACOSAMIDESmall mol.Apr 2026
  8. VIMPATLACOSAMIDESmall mol.Apr 2026
  9. VIMPATLACOSAMIDESmall mol.Apr 2026
  10. NAYZILAMMIDAZOLAMSmall mol.Jan 2028
  11. KEPPRA XRLEVETIRACETAMSmall mol.Sep 2028
  12. KEPPRA XRLEVETIRACETAMSmall mol.Sep 2028
  13. BRIVIACTBRIVARACETAMSmall mol.Apr 2030
  14. BRIVIACTBRIVARACETAMSmall mol.Apr 2030
  15. BRIVIACTBRIVARACETAMSmall mol.Apr 2030
  16. BRIVIACTBRIVARACETAMSmall mol.Apr 2030
  17. BRIVIACTBRIVARACETAMSmall mol.Apr 2030
  18. Cimziacertolizumab pegolBiologicMar 2031
  19. KEPPRALEVETIRACETAMSmall mol.Dec 2031
  20. KEPPRALEVETIRACETAMSmall mol.Dec 2031
  21. KEPPRALEVETIRACETAMSmall mol.Dec 2031
  22. KEPPRALEVETIRACETAMSmall mol.Dec 2031
  23. NEUPROROTIGOTINESmall mol.Mar 2032
  24. NEUPROROTIGOTINESmall mol.Mar 2032
  25. NEUPROROTIGOTINESmall mol.Mar 2032
  26. NEUPROROTIGOTINESmall mol.Mar 2032
  27. NEUPROROTIGOTINESmall mol.Mar 2032
  28. NEUPROROTIGOTINESmall mol.Mar 2032
  29. ZILBRYSQZILUCOPLAN SODIUMSmall mol.Jun 2035
  30. ZILBRYSQZILUCOPLAN SODIUMSmall mol.Jun 2035
  31. ZILBRYSQZILUCOPLAN SODIUMSmall mol.Jun 2035
  32. Rystiggorozanolixizumab-noliBiologicJun 2035
  33. Bimzelxbimekizumab-bkzxBiologicOct 2035
  34. Bimzelxbimekizumab-bkzxBiologicOct 2035
  35. Rystiggorozanolixizumab-noliBiologicJun 2036
  36. Rystiggorozanolixizumab-noliBiologicJun 2036
  37. Rystiggorozanolixizumab-noliBiologicJun 2036
  38. Bimzelxbimekizumab-bkzxBiologicOct 2036
  39. Bimzelxbimekizumab-bkzxBiologicOct 2036
  40. FINTEPLAFENFLURAMINE HYDROCHLORIDESmall mol.Dec 2038
  41. KYGEVVIDOXECITINE; DOXRIBTIMINESmall mol.Aug 2040
  42. DEXACORTDEXAMETHASONE SODIUM PHOSPHATESmall mol.—
  43. DEXACORTDEXAMETHASONE SODIUM PHOSPHATESmall mol.—
  44. BIPHETAMINE 12.5AMPHETAMINE RESIN COMPLEX; DEXTROAMPHETAMINE RESIN COMPLEXSmall mol.—
  45. BIPHETAMINE 20AMPHETAMINE RESIN COMPLEX; DEXTROAMPHETAMINE RESIN COMPLEXSmall mol.—
  46. BIPHETAMINE 7.5AMPHETAMINE RESIN COMPLEX; DEXTROAMPHETAMINE RESIN COMPLEXSmall mol.—
  47. IONAMINPHENTERMINE RESIN COMPLEXSmall mol.—
  48. IONAMINPHENTERMINE RESIN COMPLEXSmall mol.—
  49. GASTROCROMCROMOLYN SODIUMSmall mol.—
  50. KEPPRALEVETIRACETAMSmall mol.—
  51. KEPPRALEVETIRACETAMSmall mol.—
  52. PSEUDO-12PSEUDOEPHEDRINE POLISTIREXSmall mol.—
  53. TUSSIONEX PENNKINETICCHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREXSmall mol.—
  54. FLUXIDFAMOTIDINESmall mol.—
  55. FLUXIDFAMOTIDINESmall mol.—
  56. KEMSTROBACLOFENSmall mol.—
  57. KEMSTROBACLOFENSmall mol.—
  58. NIRAVAMALPRAZOLAMSmall mol.—
  59. NIRAVAMALPRAZOLAMSmall mol.—
  60. NIRAVAMALPRAZOLAMSmall mol.—
  61. NIRAVAMALPRAZOLAMSmall mol.—
  62. PARCOPACARBIDOPA; LEVODOPASmall mol.—
  63. PARCOPACARBIDOPA; LEVODOPASmall mol.—
  64. PARCOPACARBIDOPA; LEVODOPASmall mol.—
  65. ALBUTEROL SULFATEALBUTEROL SULFATESmall mol.—
  66. ALBUTEROL SULFATEALBUTEROL SULFATESmall mol.—
  67. AMITRIPTYLINE HYDROCHLORIDEAMITRIPTYLINE HYDROCHLORIDESmall mol.—
  68. AMITRIPTYLINE HYDROCHLORIDEAMITRIPTYLINE HYDROCHLORIDESmall mol.—
  69. AMITRIPTYLINE HYDROCHLORIDEAMITRIPTYLINE HYDROCHLORIDESmall mol.—
  70. AMITRIPTYLINE HYDROCHLORIDEAMITRIPTYLINE HYDROCHLORIDESmall mol.—
  71. AMITRIPTYLINE HYDROCHLORIDEAMITRIPTYLINE HYDROCHLORIDESmall mol.—
  72. AMITRIPTYLINE HYDROCHLORIDEAMITRIPTYLINE HYDROCHLORIDESmall mol.—
  73. CO-GESICACETAMINOPHEN; HYDROCODONE BITARTRATESmall mol.—
  74. DIETHYLPROPION HYDROCHLORIDEDIETHYLPROPION HYDROCHLORIDESmall mol.—
  75. GLUTETHIMIDEGLUTETHIMIDESmall mol.—
  76. HYDROCODONE BITARTRATE AND ACETAMINOPHENACETAMINOPHEN; HYDROCODONE BITARTRATESmall mol.—
  77. HYDROCODONE BITARTRATE AND ACETAMINOPHENACETAMINOPHEN; HYDROCODONE BITARTRATESmall mol.—
  78. LORTABACETAMINOPHEN; HYDROCODONE BITARTRATESmall mol.—
  79. LORTABACETAMINOPHEN; HYDROCODONE BITARTRATESmall mol.—
  80. UNIRETICHYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDESmall mol.—
  81. UNIRETICHYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDESmall mol.—
  82. UNIRETICHYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDESmall mol.—
  83. UNIVASCMOEXIPRIL HYDROCHLORIDESmall mol.—
  84. UNIVASCMOEXIPRIL HYDROCHLORIDESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

UCB — patent cliffs & loss of exclusivity | CliffBio